Lumen Technologies Valuation
Is LUMN * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of LUMN * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: LUMN * (MX$19.94) is trading below our estimate of fair value (MX$41.63)
Significantly Below Fair Value: LUMN * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for LUMN *?
Other financial metrics that can be useful for relative valuation.
What is LUMN *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$1.23b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.4x |
Enterprise Value/EBITDA | 4.9x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does LUMN *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.9x | ||
LASITE B-1 Sitios Latinoamérica. de | 1.3x | 11.0% | Mex$16.9b |
SITES1 A-1 Operadora de Sites Mexicanos. de | 5.2x | 5.6% | Mex$62.1b |
AXTEL CPO Axtel. de | 0.2x | 1.8% | Mex$2.5b |
1883 CITIC Telecom International Holdings | 1x | 1.9% | HK$9.9b |
LUMN * Lumen Technologies | 0.09x | -2.9% | Mex$1.2b |
Price-To-Sales vs Peers: LUMN * is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (1.9x).
Price to Earnings Ratio vs Industry
How does LUMN *'s PE Ratio compare vs other companies in the Global Telecom Industry?
Price-To-Sales vs Industry: LUMN * is good value based on its Price-To-Sales Ratio (0.1x) compared to the Global Telecom industry average (1.3x).
Price to Sales Ratio vs Fair Ratio
What is LUMN *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.09x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate LUMN *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$19.94 | Mex$28.35 +42.2% | 39.0% | Mex$59.41 | Mex$16.98 | n/a | 10 |
Apr ’25 | n/a | Mex$28.73 0% | 39.4% | Mex$58.57 | Mex$16.73 | n/a | 9 |
Mar ’25 | n/a | Mex$30.12 0% | 41.2% | Mex$59.73 | Mex$17.07 | n/a | 10 |
Feb ’25 | Mex$24.00 | Mex$33.25 +38.5% | 58.4% | Mex$86.82 | Mex$17.36 | n/a | 10 |
Jan ’25 | Mex$29.10 | Mex$33.25 +14.3% | 58.4% | Mex$86.82 | Mex$17.36 | n/a | 10 |
Dec ’24 | Mex$23.20 | Mex$33.76 +45.5% | 56.5% | Mex$86.57 | Mex$17.31 | n/a | 10 |
Nov ’24 | Mex$25.94 | Mex$39.19 +51.1% | 49.8% | Mex$89.06 | Mex$17.81 | n/a | 10 |
Oct ’24 | n/a | Mex$47.83 0% | 36.2% | Mex$86.18 | Mex$25.85 | n/a | 10 |
Sep ’24 | Mex$25.54 | Mex$50.32 +97.0% | 33.4% | Mex$85.72 | Mex$25.72 | n/a | 10 |
Aug ’24 | Mex$30.91 | Mex$53.70 +73.7% | 28.7% | Mex$84.31 | Mex$33.72 | n/a | 10 |
Jul ’24 | Mex$38.00 | Mex$58.93 +55.1% | 34.5% | Mex$102.76 | Mex$34.25 | n/a | 11 |
Jun ’24 | Mex$33.30 | Mex$65.11 +95.5% | 33.4% | Mex$106.50 | Mex$35.50 | n/a | 11 |
May ’24 | Mex$42.00 | Mex$79.56 +89.4% | 22.4% | Mex$107.88 | Mex$44.95 | n/a | 12 |
Apr ’24 | Mex$47.00 | Mex$100.16 +113.1% | 39.6% | Mex$189.88 | Mex$47.47 | n/a | 12 |
Mar ’24 | Mex$67.01 | Mex$103.07 +53.8% | 34.4% | Mex$185.16 | Mex$64.80 | n/a | 12 |
Feb ’24 | Mex$96.81 | Mex$130.42 +34.7% | 33.7% | Mex$260.69 | Mex$93.11 | Mex$24.00 | 12 |
Jan ’24 | Mex$102.00 | Mex$146.20 +43.3% | 30.3% | Mex$276.59 | Mex$98.78 | Mex$29.10 | 12 |
Dec ’23 | Mex$107.00 | Mex$147.80 +38.1% | 30.7% | Mex$272.26 | Mex$97.24 | Mex$23.20 | 10 |
Nov ’23 | Mex$147.00 | Mex$185.71 +26.3% | 31.2% | Mex$318.88 | Mex$119.58 | Mex$25.94 | 11 |
Oct ’23 | Mex$154.71 | Mex$221.26 +43.0% | 17.5% | Mex$319.19 | Mex$159.60 | n/a | 11 |
Sep ’23 | Mex$207.00 | Mex$224.00 +8.2% | 17.5% | Mex$320.52 | Mex$160.26 | Mex$25.54 | 11 |
Aug ’23 | n/a | Mex$225.52 0% | 18.3% | Mex$322.16 | Mex$161.08 | Mex$30.91 | 10 |
Jul ’23 | Mex$230.00 | Mex$225.52 -1.9% | 18.3% | Mex$322.16 | Mex$161.08 | Mex$38.00 | 10 |
Jun ’23 | Mex$230.00 | Mex$225.52 -1.9% | 18.3% | Mex$322.16 | Mex$161.08 | Mex$33.30 | 10 |
May ’23 | n/a | Mex$228.58 0% | 18.8% | Mex$326.54 | Mex$163.27 | Mex$42.00 | 10 |
Apr ’23 | n/a | Mex$229.39 0% | 19.0% | Mex$326.24 | Mex$163.12 | Mex$47.00 | 10 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.